Correlations of laparoscopy with histology and laboratory studies on liver diseases in bariatric patients

Obesity Surgery

Volumn 18, Issue 2, 2008, Pages 204-211

  Chiu, Chong Chi ^a   Lee, Wei Jei ^b   Wang, Weu ^c   Lee, Yi Chih ^b   Huang, Ming Te ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Laparoscopy; Liver biopsy; Liver disease diagnosis; Morbid obesity; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; FAT; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; ARTICLE; BARIATRIC SURGERY; CHRONIC LIVER DISEASE; COLOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LIGAMENT; LIVER BLOOD VESSEL; LIVER FIBROSIS; LIVER NODULE; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MORBID OBESITY; PERITONEAL CAVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CONTENT; SPLEEN DISEASE; SPLEEN SIZE; VARICOSIS;

ADULT; BIOPSY; FATTY LIVER; FEMALE; HUMANS; LAPAROSCOPY; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES;

EID: 39149088928     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9354-1     Document Type: Article

References (37)

1. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002;17:1136-43.
2. Arun J, Clements RH, Lazenby AJ, et al. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes Surg 2006;16:1351-8.
3. Abrams GA, Kunde SS, Lazenby AJ, et al. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 2004;40:475-83.
4. Shalhub S, Parsee A, Gallagher SF, et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 2004;14:54-9.
5. Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004;14:635-7.
6. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
7. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
8. Arun J, Jhala N, Lazenby AJ, et al. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. Obes Surg 2007;17:155-61.
9. Jalan R, Harrison DJ, Dillon JF, et al. Laparoscopy and histology in the diagnosis of chronic liver disease. QJM 1995;88:559-64.
10. Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005;242:20-8.
11. Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg 2005;15:648-54.
12. Lee WJ, Wang W, Yu PJ, et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg 2006;16:586-91.
13. Heit HA, Johnson LF, Rabin L. Liver surface characteristics as observed during laparoscopy correlated with biopsy findings. Gastrointest Endosc 1978;24:288-90.
14. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968;2:626-8.
15. Bianchi L, De Groote J, Desmet VJ. Acute and chronic hepatitis revisited. Lancet 1977;2:914-9.
16. Liu X, Lazenby AJ, Clements RH, et al. Resolution of nonalcoholic steatohepatits after gastric bypass surgery. Obes Surg 2007;17:486-92.
17. Papadia FS, Marinari GM, Camerini G, et al. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Obes Surg 2004;14:952-8.
18. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710-23.
19. Boyce HW. Diagnostic laparoscopy in liver and biliary disease. Endoscopy 1992;24:676-81.
20. Herrera JL, Brewer TG, Peura DA. Diagnostic laparoscopy: a prospective review of 100 cases. Am J Gastroenterol 1989;84:1051-4.
21. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002;17:S186-90.
22. Orlando R, Lirussi F, Okolicsanyi L. Laparoscopy and liver biopsy: further evidence that the two procedures improve the diagnosis of liver cirrhosis. A retrospective study of 1,003 consecutive examinations. J Clin Gastroenterol 1990;12:47-52.
23. Inabnet WB, Deziel DJ. Laparoscopic liver biopsy in patients with coagulopathy, portal hypertension, and ascites. Am Surg 1995;61:603-6.
24. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43:568-71.
25. Nguyen NT, Root J, Zainabadi K, et al. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg 2005;140:1198-202.
26. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
27. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg 2003;13:329-30.
28. Cardi M, Muttillo IA, Amadori L, et al. Superiority of laparoscopy compared to ultrasonography in diagnosis of widespread liver diseases. Dig Dis Sci 1997;42:546-8.
29. Pagliaro L, Rinaldi F, Craxi A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 1983;28:39-43.
30. Henning H. Indications and contraindications of diagnostic laparoscopy. Endoscopy 1992;24:674-5.
31. Helmreich-Becker I, Meyer zum Buschenfelde KH, Lohse AW. Safety and feasibility of a new minimally invasive diagnostic laparoscopy technique. Endoscopy 1998;30:756-62.
32. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-19.
33. Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002;97:2714-24.
34. Kunde SS, Lazenby AJ, Clements RH, et al. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005;42:650-6.
35. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and nonalcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006;16:1278-86.
36. Marchesini G, Forlani G. NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 2002;35:497-9.
37. Wolf AM, Busch B, Kuhlmann HW. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005;15:228-37.